The environmental impact assessment report and public participation explanation for the pilot research platform project of Shaanxi Tiandiren He Pharmaceutical Co., Ltd.'s Innovation Drug Incubation Center have been completed and are planned to be submitted for approval. In accordance with the relevant provisions of the Environmental Impact Assessment Law of the People's Republic of China and the Public Participation Measures for Environmental Impact Assessment (Order No. 4 of the Ministry of Ecology and Environment), public participation in the environmental impact assessment is now being carried out to solicit opinions and suggestions from all sectors of society on the environmental impact of the project and related environmental protection work. The public disclosure materials are as follows:

1. The full text of the environmental impact assessment report to be submitted for approval

2. Full Text of Public Participation Explanation

附件1：創(chuàng)新藥物孵化中心中試研究平臺(tái)項(xiàng)目環(huán)境影響報(bào)告書.pdf
附件2：公眾參與說明.pdf